Rasedee Abdullah

Rasedee Abdullah


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2018 in Veterinary World
Verified
Journal Article
Open access
LAL. A. Abdulkhaleq
L. A. Abdulkhaleq
MAM. A. Assi
M. A. Assi
RARasedee Abdullah
Rasedee Abdullah
MSMOHD Zamri SAAD
MOHD Zamri SAAD
Yun Hin Taufiq-YapYun Hin Taufiq-Yap
Yun Hin Taufiq-Yap
MHM. N. M. Hezmee
M. N. M. Hezmee
This review aimed to reemphasize the importance on the knowledge of inflammatory processes with the addition of newest and current issues pertaining to this phenomenon

6 August 2017 in Veterinary World
Verified
Journal Article
Open access
LALayth Abdulmajeed Abdulkhaleq
Layth Abdulmajeed Abdulkhaleq
MAMohammed Abdulrazzaq Assi
Mohammed Abdulrazzaq Assi
MNMohd Hezmee Mohd Noor
Mohd Hezmee Mohd Noor
RARasedee Abdullah
Rasedee Abdullah
MSMOHD Zamri SAAD
MOHD Zamri SAAD
Yun Hin Taufiq-YapYun Hin Taufiq-Yap
Yun Hin Taufiq-Yap
Epicatechin is a natural flavonoid found in green tea. It has been reported to possess an immense antioxidant effect which contributes to its therapeutic effect against a handful of ailments

1 January 2014 in International Journal of Nanomedicine
Verified
Journal Article
Open access
RARasedee Abdullah
Rasedee Abdullah
AAAhmad Bustaman Abdul
Ahmad Bustaman Abdul
NZNazariah Allaudin Zeenathul
Nazariah Allaudin Zeenathul
HRHeshu Rahman
Heshu Rahman
SYSwee Keong Yeap
Swee Keong Yeap
CHCw How
Cw How
This investigation evaluated the antileukemia properties of a zerumbone (ZER)-loaded nanostructured lipid carrier (NLC) prepared by hot high-pressure homogenization techniques in an acute human lymphoblastic leukemia (Jurkat) cell line in vitro. The apoptogenic effect of the ZER-NLC on Jurkat cells was determined by fluorescent and electron microscopy, Annexin V-fluorescein isothiocyanate, Tdt-mediated dUTP nick-end labeling assay, cell cycle analysis, and caspase activity. An MTT (3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide) assay showed that ZER-NLC did not have adverse effects on normal human peripheral blood mononuclear cells. ZER-NLC arrested the Jurkat cells at G2/M phase with inactivation of cyclin B1 protein. The study also showed that the antiproliferative effect of ZER-NLC on Jurkat cells is through the intrinsic apoptotic pathway via activation of caspase-3 and caspase-9, release of cytochrome c from the mitochondria into the cytosol, and subsequent cleavage of poly (adenosine diphosphate-ribose) polymerase (PARP). These findings show that the ZER-NLC is a potentially useful treatment for acute lymphoblastic leukemia in humans.

18 July 2019 in Nanomaterials
Verified
Journal Article
Open access
PDF file
MIRA NADIAH MOHD IZHAMMIRA NADIAH MOHD IZHAM
MIRA NADIAH MOHD IZHAM
Yazmin HussinYazmin Hussin
Yazmin Hussin
Muhammad Nazirul Mubin AzizMuhammad Nazirul Mubin Aziz
Muhammad Nazirul Mubin Aziz
SYSwee Keong Yeap
Swee Keong Yeap
HRHeshu Rahman
Heshu Rahman
NANoorjahan Alitheen
Noorjahan Alitheen
Citral is an active compound naturally found in lemongrass, lemon, and lime. Although this pale-yellow liquid confers low water solubility, the compound has been reported to possess good therapeutic features including antiproliferative and anticancer modalities. The self nano-emulsifying drug delivery system (SNEDDS) is a type of liquid-lipid nanocarrier that is suitable for the loading of insolubilized oil-based compound such as Citral. This study reports the design and optimization of a SNEDDS formulation, synthesis and characterization as well as loading with Citral (CIT-SNEDDS). Further assessment of theantiproliferative effects of CIT-SNEDDS towards colorectal cancer cells was also conducted. SNEDDS composed of coconut oil, dimethyl sulfoxide (DMSO) and Tween 80. CIT-SNEDDS was prepared via gentle agitation of SNEDDS with 0.5% Citral for 72 h at room temperature. Physicochemical characterization was performed using several physicochemical analyses. The average particle size of CIT-SNEDDS was16.86 ± 0.15 nm, zeta potential of 0.58 ± 0.19 mV, and polydispersity index (PDI) of 0.23 ± 0.01. In vitro drug release of Citral from CIT-SNEDDS was 79.25% of release, and for Citral the release percentage was 93.56% over 72 h. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was done to determine the cytotoxicity effect of CIT-SNEDDS in human colorectal cancer cell lines HT29 and SW620. The half maximal inhibitory concentrations (IC50) for 72 hof CIT-SNEDDS and Citral on SW620 were 16.50 ± 0.87 µg/mL and 22.50 ± 2.50 µg/mL, respectively. The IC50 values of CIT-SNEDDS and Citral after 72 h of treatment on HT29 were 34.10 ± 0.30 µg/mL and 21.77 ± 0.23 µg/mL, respectively. This study strongly suggests that CIT-SNEDDS has permitted the sustained release of Citral and that CIT-SNEDDS constitutes a potential soluble drug nanocarrier that is effective against colorectal cancer cells.

14 February 2014 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
YTYin Sim Tor
Yin Sim Tor
LYLatifah Saiful Yazan
Latifah Saiful Yazan
Jhi Biau FooJhi Biau Foo
Jhi Biau Foo
ANArmania Nurdin
Armania Nurdin
YCYoke Kqueen Cheah
Yoke Kqueen Cheah
MIMaznah Ismail
Maznah Ismail
Background: Breast cancer is one of the most dreading types of cancer among women. Herbal medicine has becoming a potential source of treatment for breast cancer. Herbal plantDillenia suffruticosa(Griff) Martelli under the family Dilleniaceae has been traditionally used to treat cancerous growth. In this study, the anticancer effect of ethyl acetate extract ofD. suffruticosa(EADs) was examined on human breast adenocarcinoma cell line MCF-7 and the molecular pathway involved was elucidated.Methods: EADs was obtained from the root ofD. suffruticosaby using sequential solvent extraction. Cytotoxicity was determined by using MTT assay, mode of cell death by cell cycle analysis and apoptosis induction by Annexin-FITC/PI assay. Morphology changes in cells were observed under inverted light microscope. Involvement of selected genes in the oxidative stress-mediated signaling pathway was explored using multiplex gene expression analysis.Results: The treatment of EADs caused cytotoxicity to MCF-7 cells in a dose- and time-dependent manner at 24, 48 and 72 hours with IC50of 76 ± 2.3, 58 ± 0.7 and 39 ± 3.6 μg/mL, respectively. The IC50of tamoxifen-treated MCF-7 cells was 8 ± 0.5 μg/mL. Induction of apoptosis by EADs was dose- and time- dependent. EADs induced non-phase specific cell cycle arrest at different concentration and time point. The multiplex mRNA expression study indicated that EADs-induced apoptosis was accompanied by upregulation of the expression ofSOD1,SOD2,NF-κB,p53,p38 MAPK, andcatalase, but downregulation ofAkt1.Conclusion: It is suggested that EADs induced apoptosis in MCF-7 cells by modulating numerous genes which are involved in oxidative stress pathway. Therefore, EADs has the potential to act as an effective intervention against breast cancer cells.

1 March 2016 in Molecules
Verified
Journal Article
Open access
PDF file
ZAZahra Ajdari
Zahra Ajdari
HRHeshu Rahman
Heshu Rahman
(6(+49)089-4140 6826
(+49)089-4140 6826
RARasedee Abdullah
Rasedee Abdullah
MGMaaruf Abd Ghani
Maaruf Abd Ghani
AAArbakariya Ariff
Arbakariya Ariff
The current study investigated the anticancer properties of gold nanoparticles (SG-stabilized AuNPs) synthesized using water extracts of the brown seaweed Sargassum glaucescens (SG). SG-stabilized AuNPs were characterized by ultraviolet-visible spectroscopy, transmission and scanning electron microscopy, and energy dispersive X-ray fluorescence spectrometry. The SG-stabilized AuNPs were stable and small at 3.65 ± 1.69 nm in size. The in vitro anticancer effect of SG-stabilized AuNPs was determined on cervical (HeLa), liver (HepG2), breast (MDA-MB-231) and leukemia (CEM-ss) cell lines using fluorescence microscopy, flow cytometry, caspase activity determination, and MTT assays. After 72 h treatment, SG-stabilized AuNPs was shown to be significant (p < 0.05) cytotoxic to the cancer cells in a dose- and time-dependent manner. The IC50 values of SG-stabilized AuNPs on the HeLa, HepG2, CEM-ss, MDA-MB-231 cell lines were 4.75 ± 1.23, 7.14 ± 1.45, 10.32 ± 1.5, and 11.82 ± 0.9 μg/mL, respectively. On the other hand, SG-stabilized AuNPs showed no cytotoxic effect towards the normal human mammary epithelial cells (MCF-10A). SG-stabilized AuNPs significantly (p < 0.05) arrest HeLa cell cycle at G2/M phase and significantly (p < 0.05) activated caspases-3 and -9 activities. The anticancer effect of SG-stabilized AuNPs is via the intrinsic apoptotic pathway. The study showed that SG-stabilized AuNPs is a good candidate to be developed into a chemotherapeutic compound for the treatment of cancers especially cervical cancer.